DDI Effectiveness and Clinical Awareness
Completed · Not applicable
Conditions studied: Drug-Drug Interactions
In brief
The DECART study will determine if primary care physicians, including internists and family physicians, are able to identify and address drug-drug interactions among simulated patients and whether those physicians, when given access to Aegis Drug-Drug Interaction test results, improve patient management, take steps to reduce DDI risk, and optimize unnecessary resource utilization.
Key facts
- Study ID
- NCT03581994
- Run by
- Qure Healthcare, LLC
- People needed
- 330
- Starts
- 2018-05-02
- Expected to finish
- 2018-08-28
- Last updated by the study team
- 2019-03-20
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Provide consent to participate in the study
- Board-certified physician currently practicing in the following areas:
- Internal medicine
- Family medicine
- Have practiced as a board-certified physician in internal or family medicine for greater than 2 but less than 30 years.
- Have not used Aegis DDI
- English-speaking
- Community/ non-academic based practice setting
- 40 patients under care weekly
- 15% of their patient panel on opioid pain medications
- Access to the internet
You may not qualify if…
- Provide consent to participate in the study
- Board-certified physician currently practicing in the following areas:
- Internal medicine
- Family medicine
- Have practiced as a board-certified physician in internal or family medicine for greater than 2 but less than 30 years.
- Have not used Aegis DDI
- English-speaking
- Community/ non-academic based practice setting
- 40 patients under care weekly
- 15% of their patient panel on opioid pain medications
- Access to the internet
Where it is running
- QURE Healthcare — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.